Treatment of myeloproliferative disease with exodus chemokine
US6096300A · kind A · utility
14Cited by
5References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 14, 1997 |
| Grant date | Aug 1, 2000 |
| Priority date | — |
| Expiry date | Nov 14, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides purified and isolated chemokine protein, fragments and polypeptide analogs thereof, antibodies thereto, and materials and methods for the recombinant production thereof. These products are useful in therapeutics, such as the treatment of myeloproliferative diseases, as well as in diagnostic and medical imaging applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.